Theralase Technologies' market value is the price at which a share of Theralase Technologies trades on a public exchange. It measures the collective expectations of Theralase Technologies investors about its performance. Theralase Technologies is trading at 0.22 as of the 12th of February 2026. This is a 4.35% down since the beginning of the trading day. The stock's lowest day price was 0.22. With this module, you can estimate the performance of a buy and hold strategy of Theralase Technologies and determine expected loss or profit from investing in Theralase Technologies over a given investment horizon. Check out Theralase Technologies Correlation, Theralase Technologies Volatility and Theralase Technologies Performance module to complement your research on Theralase Technologies.
Please note, there is a significant difference between Theralase Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Theralase Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Theralase Technologies' market price signifies the transaction level at which participants voluntarily complete trades.
Theralase Technologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Theralase Technologies' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Theralase Technologies.
0.00
11/14/2025
No Change 0.00
0.0
In 3 months and 1 day
02/12/2026
0.00
If you would invest 0.00 in Theralase Technologies on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Theralase Technologies or generate 0.0% return on investment in Theralase Technologies over 90 days. Theralase Technologies is related to or competes with Novacyt SA, Cynata Therapeutics, Sernova Corp, Bioqual, PetVivo Holdings, and Medical Developments. Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo d... More
Theralase Technologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Theralase Technologies' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Theralase Technologies upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Theralase Technologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Theralase Technologies' standard deviation. In reality, there are many statistical measures that can use Theralase Technologies historical prices to predict the future Theralase Technologies' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Theralase Technologies. Your research has to be compared to or analyzed against Theralase Technologies' peers to derive any actionable benefits. When done correctly, Theralase Technologies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Theralase Technologies.
Theralase Technologies February 12, 2026 Technical Indicators
Theralase Technologies appears to be out of control, given 3 months investment horizon. Theralase Technologies owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.14, which indicates the firm had a 0.14 % return per unit of risk over the last 3 months. By inspecting Theralase Technologies' technical indicators, you can evaluate if the expected return of 0.99% is justified by implied risk. Please review Theralase Technologies' Coefficient Of Variation of 678.78, risk adjusted performance of 0.1256, and Semi Deviation of 4.26 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Theralase Technologies holds a performance score of 11. The entity has a beta of 0.55, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Theralase Technologies' returns are expected to increase less than the market. However, during the bear market, the loss of holding Theralase Technologies is expected to be smaller as well. Please check Theralase Technologies' jensen alpha, semi variance, day typical price, as well as the relationship between the maximum drawdown and accumulation distribution , to make a quick decision on whether Theralase Technologies' existing price patterns will revert.
Auto-correlation
-0.6
Good reverse predictability
Theralase Technologies has good reverse predictability. Overlapping area represents the amount of predictability between Theralase Technologies time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Theralase Technologies price movement. The serial correlation of -0.6 indicates that roughly 60.0% of current Theralase Technologies price fluctuation can be explain by its past prices.
Other Information on Investing in Theralase OTC Stock
Theralase Technologies financial ratios help investors to determine whether Theralase OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Theralase with respect to the benefits of owning Theralase Technologies security.